ROCCA, ANDREA

ROCCA, ANDREA  

Dipartimento Universitario Clinico di Scienze mediche, chirurgiche e della salute  

Settore MED/06 - Oncologia Medica  

Ricercatori a tempo determinato  

Mostra records
Risultati 1 - 20 di 53 (tempo di esecuzione: 0.032 secondi).
Titolo Data di pubblicazione Autori File
A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study 1-gen-2019 Rocca, Andrea +
A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemo-immunotherapy in patients with advanced melanoma 1-gen-2009 Rocca A +
A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancer 1-gen-2010 Rocca A +
A randomized phase II trial comparing preoperative plus perioperative chemotherapy with preoperative chemotherapy in patients with locally advanced breast cancer 1-gen-2006 Rocca A +
Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report 1-gen-2023 Sobhani, NavidAldegheri, GiovanniRocca, AndreaGiudici, FabiolaBottin, CristinaZanconati, FabrizioGenerali, Daniele +
Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma in situ treated with surgery and radiotherapy 1-gen-2017 Rocca, Andrea +
Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases? 1-gen-2018 Rocca, Andrea +
Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy? 1-gen-2018 Rocca, Andrea +
Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial 1-gen-2018 Rocca, Andrea +
Are all high-grade breast cancers with no steroid receptor hormone expression alike? The special case of the medullary phenotype 1-gen-2005 Rocca A +
Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer? 1-gen-2020 Rocca, Andrea +
Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population? 1-gen-2018 Rocca, Andrea +
Atezolizumab Plus Nab-paclitaxel in PD-L1-Positive TNBC-Letter 1-gen-2020 Rocca, Andrea +
Can cyclin-dependent kinase 4/6 inhibitors convert inoperable breast cancer relapse to operability? A case report 1-gen-2020 Rocca, Andrea +
Can Systems Biology Advance Clinical Precision Oncology? 1-gen-2021 Rocca, Andrea +
Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer 1-gen-2020 Rocca, Andrea +
Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence 1-gen-2018 Rocca, Andrea +
Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas 1-gen-1993 Rocca A +
Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab 1-gen-2022 Rocca, Andrea +
Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis 1-gen-2022 Rocca, Andrea +